Predictive Value of Tests
"Predictive Value of Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.
Descriptor ID |
D011237
|
MeSH Number(s) |
E05.318.780.800.650 N05.715.360.780.700.640 N06.850.520.445.800.650
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Predictive Value of Tests".
Below are MeSH descriptors whose meaning is more specific than "Predictive Value of Tests".
This graph shows the total number of publications written about "Predictive Value of Tests" by people in this website by year, and whether "Predictive Value of Tests" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 19 | 19 |
1996 | 0 | 13 | 13 |
1997 | 0 | 13 | 13 |
1998 | 0 | 27 | 27 |
1999 | 0 | 20 | 20 |
2000 | 0 | 32 | 32 |
2001 | 0 | 29 | 29 |
2002 | 0 | 29 | 29 |
2003 | 0 | 40 | 40 |
2004 | 0 | 41 | 41 |
2005 | 1 | 35 | 36 |
2006 | 0 | 36 | 36 |
2007 | 0 | 53 | 53 |
2008 | 0 | 54 | 54 |
2009 | 1 | 56 | 57 |
2010 | 1 | 63 | 64 |
2011 | 1 | 76 | 77 |
2012 | 0 | 71 | 71 |
2013 | 1 | 71 | 72 |
2014 | 1 | 84 | 85 |
2015 | 2 | 95 | 97 |
2016 | 0 | 74 | 74 |
2017 | 0 | 67 | 67 |
2018 | 1 | 70 | 71 |
2019 | 0 | 71 | 71 |
2020 | 0 | 53 | 53 |
2021 | 0 | 38 | 38 |
2022 | 0 | 10 | 10 |
2023 | 0 | 17 | 17 |
2024 | 14 | 22 | 36 |
To return to the timeline,
click here.
Below are the most recent publications written about "Predictive Value of Tests" by people in Profiles.
-
How to Use Imaging: Complex Cases of Atherosclerosis, Myocardial Inflammation, and Cardiomyopathy in Cardio-Oncology. Circ Cardiovasc Imaging. 2025 Jan; 18(1):e015981.
-
International workshop: what is needed to ensure outcome measures for Rett syndrome are fit-for-purpose for clinical trials? June 7, 2023, Nashville, USA. Trials. 2024 Dec 21; 25(1):845.
-
Management of acute chest pain in the Emergency Department: benefits of coronary computed tomography angiography. Int J Cardiovasc Imaging. 2024 Dec; 40(12):2447-2457.
-
Age modulates the predictive value of self-reported sleepiness for all-cause mortality risk: insights from a comprehensive national database of veterans. J Clin Sleep Med. 2024 Nov 01; 20(11):1785-1792.
-
Cardiac MRI Predictors of Arrhythmic?Sudden Cardiac Events in Patients With Fontan Circulation. J Am Coll Cardiol. 2024 Dec 17; 84(25):2417-2426.
-
Characterization and z-score calculation of cardiovascular magnetic resonance imaging parameters in patients after the Fontan operation: A Fontan Outcome Registry using Cardiovascular Magnetic Resonance Examinations study. J Cardiovasc Magn Reson. 2024 Winter; 26(2):101113.
-
Serum levels of total bile acids are associated with an increased risk of HCC in patients with cirrhosis. Hepatol Commun. 2024 Nov 01; 8(11).
-
Does a Concise Patient-reported Outcome Measure Provide a Valid Measure of Physical Function for Cancer Patients After Lower Extremity Surgery? Clin Orthop Relat Res. 2025 Jan 01; 483(1):62-75.
-
Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor-Positive Breast Cancer. JAMA Oncol. 2024 Oct 01; 10(10):1379-1389.
-
Predictive Significance of Combined Plasmatic Detection of BRAF Mutations and S100B Tumor Marker in Early-Stage Malignant Melanoma. Cancer Med. 2024 Oct; 13(19):e70313.